β2-glycoprotein I protects J774A.1 macrophages and human coronary artery smooth muscle cells against apoptosis

Journal of Cellular Biochemistry

Volumn 94, Issue 3, 2005, Pages 485-496

  Lin, Kae Yuan ^a   Wang, Hsueh Hsiao ^a   Lai, Shiau Ting ^b   Pan, Ju Pin ^b   Chiang, An Na ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

2 Glycoprotein I; Apoptosis; Coronary artery smooth muscle cells; Macrophages; Nitric oxide

Indexed keywords

BETA2 GLYCOPROTEIN 1; CASPASE 3; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PROTEIN C FOS; PROTEIN C JUN; S NITROSOGLUTATHIONE; GLYCOPROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SHAPE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMOOTH MUSCLE FIBER; CORONARY BLOOD VESSEL; CYTOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADULT; AGED; BETA 2-GLYCOPROTEIN I; BLOTTING, WESTERN; CORONARY VESSELS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 23044460533     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20314     Document Type: Article

References (68)

1. Alencar JL, Lobysheva I, Chalupsky K, Geffard M, Nepveu F, Stoclet JC, Muller B. 2003. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries. J Pharmacol Exp Ther 307:152-159.
2. 2- Glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 67:649-653.
3. Brighton TA, Dai YP, Hegg PJ, Chesterman CN. 1999. Microheterogeneity of beta-2-glycoprotein I: Implications for binding to anionic phospholipids. Biochem J 340:59-67.
4. Brüne B, Golkel C, von Knethen A. 1996. Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW264.7 macrophages. Biochem Biophys Res Commun 229:396-401.
5. Callsen D, Brüne B. 1999. Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry 38:2279-2286.
6. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rose A. 1994. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 269:30757-30760.
7. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Cark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. 1996. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316-327.
8. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. 2001. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282:1075-1079.
9. 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci USA 98:13826-13831.
10. Drouet B, Fifre A, Pincon-Raymond M, Vandekerckhove J, Rosseneu M, Gueant JL, Chambaz J, Pillot T. 2001. ApoE protects cortical neurons against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide. J Neurochem 76:117-127.
11. Estus S, Zaks BJ, Freeman RS, Gruda M, Bravo R, Johnson EM. 1994. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127:1717-1727.
12. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
13. Haunstetter A, Izumo S. 1998. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 82:1111-1129.
14. Heneka MT, Loschmann PA, Gleichmann M, Weller M, Schulz JB, Wullner U, Klockgether T. 1998. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha lipopolysaccharide. J Neurochem 71:88-94.
15. Hirvonen MR, Brüne B, Lapetina EG. 1996. Heat shock proteins and macrophage resistance to the toxic effects of nitric oxide. Biochem J 315:845-849.
16. James TN, St Martin E, Willis PW, Lohr TO. 1996. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation 93:1424-1438.
17. Kandiah DA, Sali A, Sheng Y, Victoria EJ, Marquis DM, Coutts SM, Krilis SA. 1998. Current insights into the "antiphospholipid" syndrome: Clinical, immunological, and molecular aspects. Adv Immunol 70:507-563.
18. Kato H, Enjyoji K. 1991. Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: The presence of five Sushi domains. Biochemistry 30:11687-11694.
19. Kim YM, Bergonia H, Lancaster JR, Jr. 1995. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett 374:228-232.
20. Kockx MM, Herman AG. 2000. Apoptosis in atherosclerosis: Beneficial or detrimental? Cardiovasc Res 45:736-746.
21. Kockx MM, Knaapen MW. 2000. The role of apoptosis in vascular disease. J Pathol 190:267-280.
22. Koglin J, Granville DJ, Glysing-Jensen T, Mudgett JS, Carthy CM, McManus BM, Russell ME. 1999. Attenuated acute cardiac rejection in NOS 2 -/- recipients correlates with reduced apoptosis. Circulation 99:836-842.
23. Kolodgie FD, Narula J, Haider N, Virmani R. 2001. Apoptosis in atherosclerosis. Does it contribute to plaque instability? Cardiol Clin 19:127-139.
24. Kroncke KD, Fehsel K, Kolb-Bachofen V. 1997. Nitric oxide: Cytotoxicity versus cytoprotection-How, why, when, and where? Nitric Oxide 1:107-120.
25. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Bartimore D, Weintraub H. 1991. Functional activity of myogenic HLH proteins requires heterooligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
26. 2-Glycoprotein I: Molecular properties of an unusual apolipoprotein, apolipoprotein H. J Biol Chem 258:4765-4770.
27. Li PF, Dietz R, von Harsdorf R. 1997. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96:3602-3609.
28. Li J, Li PF, Dietz R, von Harsdorf R. 2002. Intracellular superoxide induces apoptosis in VSMCs: Role of mitochondrial membrane potential, cytochrome C and caspases. Apoptosis 7:511-517.
29. Liby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. 1996. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7:330-335.
30. 2-glycoprotein I). Life Sci 69:707-719.
31. Mallat Z, Tedgui A, Fontaliran F, Frank R, Duigon M, Fontaine G. 1996. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. New Engl J Med 335:1190-1196.
32. Mallat Z, Ohan J, Lesèche G, Tedgui A. 1997. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation 96:424-428.
33. 2-glycoprotein I. Arthritis Rheum 41:215-223.
34. Mathews WR, Kerr SW. 1993. Biological activity of S-nitrosothiols: The role of nitric oxide. J Pharmacol Exp Ther 267:1529-1537.
35. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. 1990. Anti-phospholipid antibodies are direct against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120-4124.
36. Messmer UK, Lapetina EG, Brüne B. 1995. Nitric oxide-induced apoptosis in RAW264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol 47:757-765.
37. Messmer UK, Reimer DM, Reed JC, Brüne B. 1996. Nitric oxide induced poly (ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2. FEBS Lett 384:162-166.
38. Mohr S, McCormick TS, Lapetina EG. 1998. Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: Dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. Proc Natl Acad Sci USA 95:5045-5050.
39. Muthukkumar S, Nair P, Sells SF, Maddiwar NG, Jacob RJ, Rangnckar VM. 1995. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol Cell Biol 15:6262-6272.
40. Nishio E, Watanabe Y. 1998. NO induced apoptosis accompanying the change of oncoprotein expression and the activation of CPP32 protease. Life Sci 62:239-245.
41. L induced in activated macrophages. J Immunol 160:2590-2596.
42. Pang JHS, Chau LY. 1999. Copper-induced apoptosis and immediate early gene expression in macrophages. Atherosclerosis 146:45-52.
43. Pedersen WA, Chan SL, Mattson MP. 2000. A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J Neurochem 74:1426-1433.
44. Polz E. 1988. Isolation of a specific lipid-binding protein from human serum by affinity chromatography using heparin-Sepharose. In: Peeters H, editor. Provides of biological fluids. Oxford: Pergamon Press, pp 817-820.
45. 2-glycoprotein I. Artery 9:305-315.
46. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA, Barrett JC. 1996. Induction of apoptosis by c-Fos protein. Mol Cell Biol 16:211-218.
47. Ramachandran A, Levonen AL, Brookes PS, Ceaser E, Shiva S, Barone MC, Darley-Usmar V. 2002. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med 33:1465-1474.
48. Ravalli S, Szabolcs M, Albala A, Michler RE, Cannon PJ. 1996. Increased immunoreactive endothelin-1 in human transplant coronary artery disease. Circulation 94:2096-2102.
49. Roubey RA, Hoffman M. 1997. From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 350:1491-1493.
50. Rudel T, Bokoch M. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276:1571-1574.
51. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. 2002. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585:213-221.
52. 2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 6:311-316.
53. Schlegel RA, Williamson P. 2001. Phosphatidylserine, a death knell. Cell Death Differ 8:551-563.
54. 2- glycoprotein I null mice. J Biol Chem 276:13817-13821.
55. 2-GPI in the antiphospholipid (Hughes') syndrome-From a cofactor to an autoantigen-From induction to prevention of antiphospholipid syndrome. Lupus 7:503-506.
56. Song Q, Lees-Miller SP, Kumar S, Zhang Z, Chen DW, Smith GC, Jackson SP, Alnemri ES, Litwack G, Khanna KK, Lavin MF. 1996. DNA-dependent protein kinase catalytic subunit: A target for an ICE-like protease in apoptosis. EMBO J 15:3238-3246.
57. Stennicke HR, Salvesen GS. 1998. Properties of the caspases. Biochim Biophys Acta 1387:17-31.
58. Suc I, Escargueil-Blanc I, Troly M, Salvayre R, Nègre-Salvayre A. 1997. HDL and apoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler Thromb Vasc Biol 17:2158-2166.
59. 2-glycoprotein I deficiency. Blood 96:1594-1595.
60. Teng CS. 2000. Protooncogenes as mediators of apoptosis. Int Rev Cytol 197:137-202.
61. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. 1995. Yama/CPP32 beta, a mammalian homology of CED-3 is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose)polymerase. Cell 81:801-809.
62. Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D. 1994. Exposure of anionic phospholipids upon platelet activation permits binding of p2-glycoprotein I and through it that of IgG antiphospholipid syndrome and normal subjects. J Autoimmun 7:335-348.
63. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J, French LE. 1999. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112:290-296.
64. Walsh K, Smith RC, Kim HS. 2000. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ Res 87:184-188.
65. Wang N, Verna L, Hardy S, Zhu Y, Ma KS, Birrer MJ, Stemerman MB. 1999. c-Jun triggers apoptosis in human vascular endothelial cells. Circ Res 85:387-393.
66. Yao M, Keogh A, Spratt P, dos Remedios CG, Kiessling PC. 1996. Elevated DNase I levels in human idiopathic dilated cardiomyopathy. An indicator of apoptosis? J Mol Cell Cardiol 28:95-101.
67. 2-Glycoprotein I deficiency: Prevalence, genetic background, and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis 152:337-346.
68. Zhang H, Snead C, Catravas JD. 2001. Nitric oxide differently regulates induction of type II nitric oxide synthase in rat vascular smooth muscle cells versus macrophages. Arterioscler Thromb Vasc Biol 21:529-535.